Roche Ducks FCA Suit Over Nonexistent Lab Tests

Law360, New York (January 2, 2014, 5:56 PM EST) -- A New York federal judge scrapped a False Claims Act suit accusing Roche Diagnostics Corp. of indirectly defrauding Medicare by failing to address glitches in its laboratory devices, finding Monday that a whistleblower’s allegations of bogus billing were too murky.

The ruling, which also weighed in on a budding controversy surrounding the FCA’s public disclosure bar, found that while Roche devices may have exaggerated the number of tests performed, there was no evidence of the federal government actually being charged for services that weren’t provided....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

United States of America v. Roche Diagnostics, Corp. et al


Case Number

2:11-cv-05378

Court

New York Eastern

Nature of Suit

Other Statutory Actions

Judge

Arthur D. Spatt

Date Filed

November 2, 2011

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.